XmAb-2513

• Target:

  TNF

• Related Pathways:

  Apoptosis

• Bioactivity:

  XmAb-2513 is a humanized monoclonal antibody inhibitor targeting CD30. It demonstrates significant anti-proliferative activity along with excellent antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP) . XmAb-2513 is applicable in research on hematological malignancies such as Hodgkin lymphoma (HL) and anaplastic large cell lymphoma (ALCL) .

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C